Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  1, 1017 - 1023 (1995)
doi:10.1038/nm1095-1017

Engraftment of gene−modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

Donald B. Kohn1, 9, Kenneth I. Weinberg1, Jan A. Nolta1, Linda N. Heiss1, Carl Lenarsky1, Gay M. Crooks1, Mary E. Hanley1, Geralyn Annett1, Judith S. Brooks1, Anthony El-Khoureiy1, Kim Lawrence1, Susie Wells1, Robert C. Moen2, John Bastian3, Debora E. Williams-Herman4, Melissa Elder4, Diane Wara4, Thomas Bowen5, Michael S. Hershfield6, Craig A. Mullen7, 8, R. Michael Blaese7 & Robertson Parkman1

  1Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital, Los Angeles, University of Southern California School of Medicine, 4650 Sunset Boulevard, Los Angeles, California 90027, USA

  2Genetic Therapy, Inc., 938 ClopperRoad, Gaithersburg, Maryland 20878, USA

  3Children's Hospital and Health Center, San Diego, California 92123, USA

  4Department of Pediatrics, University of California at San Francisco, San Francisco, California 94143, USA

  51842 Oak Bay, Victoria, BC, Canada, V8R 1C2

  6Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA

  7National Center for Human Genome Research, National Institutes of Health, Building 49, Room 2A03, 4900 Convent Drive, Bethesda, Maryland 20892-4430, USA

  8Present address: Department of Experimental Pediatrics, Univeristy of Texas M.D. Anderson Cancer Center, Box 88, Room AC6.004, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

  9Correspondence should be addressed to D.B.K.

Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral−mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.

REFERENCES
  1. Giblett, E.R., Anderson, J.E., Cohen, F., Pollara, B. & Meuwissen, H.J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2, 1067−1069 (1972). | Article | PubMed  | ISI | ChemPort |
  2. Hershfield, M.S. & Mitchell, B.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. in The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 1725−1768 (McGraw-Hill, New York, 1994).
  3. Parkman, R., Gelfand, E.W., Rosen, F.S., Sanderson, A. & Hirschhorn, R. Severe combined immunodeficiency and adenosine deaminase. New Engl. J. Med. 292, 714−719 (1975). | PubMed  | ISI | ChemPort |
  4. Weinberg, K.I. & Kohn, D.B. Somatic gene therapy for severe combined immunodeficiency (SCID). in Somatic Gene Therapy (ed. Chang, P.) 31−47 (CRC Press, Boca Raton, 1995).
  5. Blaese, R.M. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr. Res. 33 (suppl.), S49−S55 (1993). | PubMed  | ISI | ChemPort |
  6. Hershfield, M.S., Chaffee, S. & Sorensen, R.U. Enzyme replacement therapy with PEG-ADA in adenosine deaminase deficiency: Overview and case report of three patients, including two now receiving gene therapy. Pediatr. Res. 33 (suppl.), S42−S48 (1993). | PubMed  | ISI | ChemPort |
  7. Broxmeyer, H.E., Cooper, S., Yoder, M. & Hangoc, G. Human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells. Curr. Topics Microbiol. Immunol. 177, 195−204 (1992). | ISI | ChemPort |
  8. Wagner, J.E. et al. Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment. Blood 79, 1874−1881 (1992). | PubMed  | ISI | ChemPort |
  9. Hock, R.A., Miller, A.D. & Osborne, W.R. Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74, 876−881 (1989). | PubMed  | ISI | ChemPort |
  10. Williams, D.A., Lemischka, I.R., Nathan, D.G. & Mulligan, R.C. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310, 476−480 (1984). | PubMed  | ISI | ChemPort |
  11. Jordan, C.T. & Lemischka, I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4, 220−232 (1990). | PubMed  | ISI | ChemPort |
  12. Triglia, T., Peterson, M.G. & Kemp, D.J. A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Adds Res. 16, 8186 (1988). | ChemPort |
  13. Ochman, H., Gerber, A.S. & Hartl, D.L. Genetic applications of an inverse polymerase chain reaction. Genetics 120, 621−623 (1988). | PubMed  | ISI | ChemPort |
  14. Rill, D.R. et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84, 380−383 (1994). | PubMed  | ISI | ChemPort |
  15. Harrison, D.E. Competitive repopulation in unirradiated normal recipients. Blood 81, 2473−2474 (1993). | PubMed  | ISI | ChemPort |
  16. Stewart, F.M., Crittenden, R.B., Lowry, P.A., Pearson-White, S. & Quesenberry, P.J. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81, 2566−2571 (1993). | PubMed  | ISI | ChemPort |
  17. Wu, D.D. & Keating, A. Hematopoietic stem cells engraft in untreated transplant recipients. Expl. Hematol. 21, 251−256 (1993). | ChemPort |
  18. Van Beusechem, V.W., Kakler, A., Meidt, P.J. & Valerio, D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone marrow cells. Proc. natn. Acad. Sci. U.S.A. 79, 7640−7644 (1992).
  19. Bodine, D.M. et al. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood 82, 1975−1980 (1993). | PubMed  | ISI | ChemPort |
  20. Brenner, M.K. et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134−1137(1993). | Article | PubMed  | ISI | ChemPort |
  21. Valera, A., Perales, J.C., Hatzoglou, M. & Bosch, F. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449−456 (1994). | PubMed  | ISI | ChemPort |
  22. Von Melchner, H. & Housman, D.E. The expression of neomycin phospho-transferase in human promyelocytic leukemia cells (HL-60) delays their differentiation. Oncogene 2, 137−140 (1988). | PubMed  | ChemPort |
  23. Miller, A.D. & Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Molec. cell. Biol. 6, 2895−2902 (1986). | PubMed  | ISI | ChemPort |
  24. Bassin, R.H., Tuttle, N. & Fischinger, P.J. Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int. J. Cancer 6, 95−107 (1970). | PubMed  | ISI | ChemPort |
  25. Hanley, M.E., Nolta, J.A., Parkman, R. & Kohn, D.B. Umbilical cord blood cell transduction by retroviral vectors: Pre-clinical studies to optimize gene transfer. Blood Cells 20, 539−546 (1994). | PubMed  | ISI | ChemPort |
  26. Hershfield, M.S. et al. Treatment of adenosine deaminase deficiency with polyethylene glycol-modifled adenosine deaminase. New Engl. J. Med. 316, 589−596 (1987). | PubMed  | ISI | ChemPort |
  27. Nolta, J.A. & Kohn, D.B. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum. Gene Ther. 1, 257−268 (1990). | PubMed  | ISI | ChemPort |
  28. Nolta, J.A., Yu, X.J., Bahner, I. & Kohn, D.B. Retroviral mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J. clin. Invest. 90, 343−348 (1992).
  29. Weinberg, K. & Parkman, R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. New Engl. J. Med. 322, 1718−1723 (1990). | PubMed  | ISI | ChemPort |
  30. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction. Anal. Biochem. 162, 156−159 (1987). | Article | PubMed  | ISI | ChemPort |
  31. Arredondo-Vega, F.X. et al. Paradoxical expression of adenosine deaminase in T cell cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency. J. clin. Invest. 86, 444−452 (1990). | PubMed  | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1995 Nature Publishing Group | Privacy policy